PRESS RELEASE published on 02/01/2024 at 12:30, 2 years 3 months ago Immunic to Participate in Investor and Scientific Conferences in February Immunic, Inc. (Nasdaq: IMUX) to participate in BioCapital Europe 2024 and ACTRIMS Forum 2024 in February and March, presenting clinical pipeline therapies and poster presentations Immunic, Inc. BioCapital Europe 2024 ACTRIMS Forum 2024 Clinical Pipeline Therapies Poster Presentations
PRESS RELEASE published on 11/02/2023 at 11:30, 2 years 6 months ago Immunic Receives Notice of Allowance for United States Patent Protecting the Treatment of Relapsing Multiple Sclerosis with Vidofludimus and Its Salts
PRESS RELEASE published on 10/26/2023 at 12:30, 2 years 6 months ago Immunic to Participate in Scientific and Industry Conferences in November
PRESS RELEASE published on 10/16/2023 at 12:30, 2 years 6 months ago Immunic Presents Data From Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Ulcerative Colitis at the United European Gastroenterology Week 2023
PRESS RELEASE published on 10/15/2023 at 12:30, 2 years 6 months ago Immunic Presents Data From Phase 1b Clinical Trial of IMU-856 in Celiac Disease at the United European Gastroenterology Week 2023
PRESS RELEASE published on 10/11/2023 at 12:30, 2 years 6 months ago Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023: The 9th Joint ECTRIMS-ACTRIMS Meeting
PRESS RELEASE published on 10/09/2023 at 22:01, 2 years 6 months ago Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
PRESS RELEASE published on 10/04/2023 at 12:30, 2 years 7 months ago Immunic to Participate in Scientific Conferences in October
PRESS RELEASE published on 09/06/2023 at 12:30, 2 years 7 months ago Immunic to Participate in Industry and Investor Conferences in September
PRESS RELEASE published on 08/17/2023 at 12:30, 2 years 8 months ago Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
Published on 05/06/2026 at 02:17, 5 hours 35 minutes ago Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 5 hours 52 minutes ago Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 02:00, 5 hours 52 minutes ago Alset AI Announces Shares for Debt Transaction
Published on 05/06/2026 at 01:30, 6 hours 22 minutes ago Presentation to RIU Sydney Resources Roundup
Published on 05/06/2026 at 01:20, 6 hours 32 minutes ago Empress Grants Stock Options and Equity Incentives
Published on 05/06/2026 at 07:30, 22 minutes ago BIKE24 off to a strong start in 2026 – 21.9% revenue growth and a significant improvement in adjusted EBITDA to EUR 1.8 million
Published on 05/06/2026 at 07:30, 22 minutes ago Masterflex starts the 2026 financial year with stable revenue development and increasing profitability – guidance confirmed
Published on 05/06/2026 at 07:30, 22 minutes ago Mutares has sold Peugeot Motocycles to its Management
Published on 05/06/2026 at 07:30, 22 minutes ago ZEAL grows despite weak jackpot situation and further expands its product portfolio
Published on 05/06/2026 at 07:30, 22 minutes ago Growth prospects improved: Infineon raises full-year guidance. AI boom strengthens further. Automotive order intake improves. Revised segment structure effective from the fourth quarter
Published on 05/05/2026 at 19:00, 12 hours 52 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 19:00, 12 hours 52 minutes ago Assemblée Générale Mixte des Actionnaires d’Air Liquide du 5 mai 2026
Published on 05/05/2026 at 18:40, 13 hours 12 minutes ago Mise en œuvre du programme de rachat d’actions
Published on 05/05/2026 at 18:03, 13 hours 49 minutes ago Aéroports de Paris SA - Actions et droits de vote au 30 avril 2026
